As it has for everything else, AI has now come for the accent. Companies like Krisp and Sanas sell real-time accent ...
Drones represent a defining dual-use technology of this era, which presents a compelling reason for India to keep its supply ...
Pemivibart has been available in the US since March 2024 under an emergency use authorisation for adults and adolescents aged ...
Zohran Mamdani’s surging mayoral campaign in New York City embodies, for many, the promise of a new wave of democratic ...
New long-term extension data show approximately 80% of patients achieved or maintained meaningful skin improvement (EASI 75) with EBGLYSS with half the ...
UCB, a global biopharmaceutical company, today announced new three-year data from Phase 3 trials, and their open-label extensions, investigating BIMZELX® (bimekizumab-bkzx) in adults with active ...
New long-term extension data show approximately 80% of patients achieved or maintained meaningful skin improvement (EASI 75) with EBGLYSS with half the doses compared ...
Background Anti-C1q autoantibodies can disrupt normal complement function, contributing to the formation of pathogenic immune ...
Congress failed to reach a funding deal by the Wednesday, Oct. 1, deadline, leading to a government shutdown that will force active-duty service members to continue to serve without pay until a deal ...